UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000052799
Receipt number R000060226
Scientific Title Investigation of the Optical Frequency Domain Imaging-guided drug-coated balloon therapy for femoropopliteal in-stent restenosis
Date of disclosure of the study information 2023/11/14
Last modified on 2023/11/14 17:52:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

INFINITY ISR

Acronym

INFINITY ISR

Scientific Title

Investigation of the Optical Frequency Domain Imaging-guided drug-coated balloon therapy for femoropopliteal in-stent restenosis

Scientific Title:Acronym

INFINITY ISR

Region

Japan


Condition

Condition

In-stent restenosis: ISR

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Investigation of the Optical Frequency Domain Imaging-guided drug-coated balloon therapy for femoropopliteal in-stent restenosis

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

at 12-month follow-up

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

-Over 20 years old
-Patients with symptomatic lower extremity arteriosclerosis obliterans (Rutherford Classification 2-5)
-Patients treated with OFDI-guided DCB for ISR of the femoral popliteal artery (any type of stent presenting ISR)

Key exclusion criteria

-Lesions with confirmed stent fractures of type III or greater
-Lesions with two or more stents stacked on top of each other
-Lesions implanted with a combination of two or more stents

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Tatsuya
Middle name
Last name Nakama

Organization

Tokyo Bay Urayasu Ichikawa Medical Center

Division name

Cardiology

Zip code

279-0001

Address

3-4-32 Todaijima, Urayasu-City, Chiba

TEL

047-351-3101

Email

tatsuya_nakama@med.miyazaki-u.ac.jp


Public contact

Name of contact person

1st name Tatsuya
Middle name
Last name Nakama

Organization

Tokyo Bay Urayasu Ichikawa Medical Center

Division name

Cardiology

Zip code

279-0001

Address

3-4-32 Todaijima, Urayasu-City, Chiba

TEL

047-351-3101

Homepage URL


Email

tatsuya_nakama@med.miyazaki-u.ac.jp


Sponsor or person

Institute

Tokyo Bay Urayasu Ichikawa Medical Center

Institute

Department

Personal name



Funding Source

Organization

Tokyo Bay Urayasu Ichikawa Medical Center

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Bay Urayasu Ichikawa Medical Center

Address

3-4-32 Todaijima, Urayasu-City, Chiba

Tel

047-351-3101

Email

tatsuya_nakama@med.miyazaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 11 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

116

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 06 Month 21 Day

Date of IRB

2022 Year 08 Month 05 Day

Anticipated trial start date

2022 Year 08 Month 09 Day

Last follow-up date

2024 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Study Design: Observational study
Target population:Symptomatic atherosclerosis obliterans treated with an optical coherence tomography-guided, drug-coated balloon for in-stent restenosis in the femoral popliteal artery territory


Management information

Registered date

2023 Year 11 Month 14 Day

Last modified on

2023 Year 11 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060226


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name